Objective: To assess pre-AIDS mortality in HIV-infected patients in England, Wales and Northern Ireland during the period 1982-1996.
Design: Surveillance data on pre-AIDS and AIDS deaths reported to the PHLS-AIDS Centre were analysed.
Methods: Pre-AIDS mortality was estimated as the proportion of pre-AIDS deaths among all deaths in HIV-infected people. Trends over time in the number of pre-AIDS and AIDS deaths were compared using Poisson regression with logarithmic link. Causes of pre-AIDS deaths were recorded. Comparisons were made between the pre-AIDS and the AIDS death groups by logistic regression for: age, location of residence at death, year of death and risk exposure.
Results: Four-hundred and sixty-eight pre-AIDS deaths and 8574 AIDS deaths were identified. Pre-AIDS mortality accounted for 5.0% of HIV-related deaths. Trends over time in the number of pre-AIDS and AIDS deaths were not significantly different (P=0.11). Reported causes of pre-AIDS death included pneumonia (92), liver disease (62), septicaemia (51), malignancies (49), suicide (45), cardiopulmonary causes (46), haemorrhage (42), overdose (24) and accidental causes (24). Factors positively associated with pre-AIDS death were injecting drug use, haemophilia and blood transfusion, residence outside the Thames regions, and death at an older age.
Conclusions: Pre-AIDS mortality represents a substantial proportion of HIV mortality, particularly where injecting drug use is a frequent route of HIV transmission.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/00002030-199806000-00015 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mortality variability and differentials by age and causes of death in rural South Africa, 1994-2018.
BMJ Glob Health
April 2024
School of Demography, The Australian National University, Acton, Australian Capital Territory, Australia.
Introduction: Understanding mortality variability by age and cause is critical to identifying intervention and prevention actions to support disadvantaged populations. We assessed mortality changes in two rural South African populations over 25 years covering pre-AIDS and peak AIDS epidemic and subsequent antiretroviral therapy (ART) availability.
Methods: Using population surveillance data from the Agincourt Health and Socio-Demographic Surveillance System (AHDSS; 1994-2018) and Africa Health Research Institute (AHRI; 2000-2018) for 5-year periods, we calculated life expectancy from birth to age 85, mortality age distributions and variation, and life-years lost (LYL) decomposed into four cause-of-death groups.
[Natural history of HIV infections among injecting drug users in Dehong prefecture, Yunnan province].
Zhonghua Liu Xing Bing Xue Za Zhi
July 2010
Dehong Center for Disease Control and Prevention, Luxi 678400, China.
Article Synopsis
- The study aimed to track the long-term outcomes of HIV-1 infection among intravenous drug users (IDUs) in Yunnan province, China, beginning in late 1989, focusing on survival factors.
- Over a 20-year follow-up of 196 initial subjects, 90.3% died, with notable causes of death including diseases like malaria and septicemia, as well as drug overdoses.
- Findings indicated that median survival times were shorter than those typically seen in developed countries, with older age at infection linked to reduced survival.
[Profiles of multiple causes of death related to HIV/AIDS in the cities of São Paulo and Santos, Brazil, 2001].
Cad Saude Publica
March 2007
Department of Population Health Sciences, University of Wisconsin Medical School, Madison, WI, USA.
Following the introduction of highly active antiretroviral therapy (HAART), the HIV-related morbidity-mortality profile has changed. Opportunistic infections are not as prevalent as before, and "pre-AIDS" diseases have become more common, related mostly to the side effects of HAART. This study focused on HIV/AIDS-related mortality, based on multiple causes of death among individuals who died of HIV-related causes in the cities of São Paulo and Santos, Brazil, in 2001.
View Article and Find Full Text PDFIncluding pre-AIDS mortality in back-calculation model to estimate HIV prevalence in France, 2000.
Eur J Epidemiol
March 2007
CRESGE-LEM, CNRS UMR 8179, Lille, France.
Since the advent of highly active antiretroviral therapy (HAART) the lengthening of AIDS incubation time has led to a decrease of AIDS incidence and mortality, and to the increase of the proportion of pre-AIDS mortality. The objective was to develop an extension of the back-calculation model by including pre-AIDS mortality and to estimate HIV prevalence in France. Our previous back-calculation model was modified to take into account the probability of survival for HIV-infected individual using the relative risk to die at different period for an HIV-infected person versus the general population (psi).
View Article and Find Full Text PDFBackground: There are few data about disease progression and response to antiretroviral therapy (ART) in vertically HIV-infected infants in the era of effective therapy.
Design: Cohort study.
Methods: We examined progression to acquired immunodeficiency syndrome (AIDS) and death over calendar time for infants reported to the National Study of HIV in Pregnancy and Childhood in the United Kingdom/Ireland.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!